Q4 2025 earnings call recap: revenue/EPS beat, 2026 guidance, product relaunches, cash flow outlook, and tariff risks—read now.
Q4 2025 earnings call recap: revenue up 11% to $99M, 87%+ gross margins, improving cash flow, pricing hike & AI focus—read now.
That promise now rings hollow for many, especially after his decision to strike Iran last week. Since the attacks began Saturday, six U.S. service members have been killed. Oil prices are rising. Gulf ...
Billionaire Peter Thiel is an entrepreneur and venture capitalist that co-founded Palantir Technologies, where he still ...
Gear Patrol on MSN
That OneFossil Watch Everyone Wanted in Middle School Is Finally Back
Don't pretend you don't still want one.
Our reporters unpack the strategy, risks and politics behind Trump’s Iran strikes.
6-211*: ED Mason Reiger (Wisconsin | No. 255): Reiger is a tall and skinny edge rusher who found success with Wisconsin last ...
Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced its financial results for the fourth quarter and ...
Power outages have become increasingly common, and longer in duration, due to extreme weather and temperature events. Behind-the-meter (BTM) batteries are proving their worth, as they have become more ...
These companies are diversified technology players benefiting from the latest innovations in artificial intelligence (AI).
Strategic leadership changes -- Eran Ophir became CEO in September 2025, with Anat Cohen-Dayag transitioning to Executive Chair to enhance operational focus and strategic continuity.
RIVKIN Aesthetics reports the rise of weight loss drugs like GLP-1 is reshaping aesthetics, with many new patients seeking facial treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results